‘EXPLORING POSSIBILITIES OF STRATEGIC TIE-UPS WITH HOSPITAL CHAINS’

“On the back of our record Q2FY22 performance with all-time high operating financials and highest ever monthly and quarterly revenue and EBITDA, we expect even higher footfalls going forward – both from domestic and international patients - to enable all HCG centres to continue their scale-up trajectory. The upsurge in Maharashtra centres is expected to scale new highs, having already delivered 17.5 per cent revenue growth q-o-q. East India and North India are likely to gain further momentum in their high-growth trajectories. Stepping into the new year, we will continue to optimise capital allocations around cancer care. M&A is an integral part of our strategy, and given our demonstrated capability to integrate acquisitions, we will continue to eye emerging geographies to deliver focused medical care in micromarkets and further consolidate our dominant position. We will reap the synergetic benefits of our majority stake in Suchirayu Healthcare Solutions, which owns a multi-speciality hospital in Hubli. We will also explore possibilities of strategic tie-ups with hospital chains in the developing world to extend our expertise driven by need. A case in point is our collaboration with Al Hayat International Hospital which is focused on strengthening Oman’s cancer care expertise through virtual video consultations with expert cancer specialists from HCG Chain of Hospitals, India.” - DR B. S. AJAIKUMAR, Executive Chairman, HealthCare Global Enterprises, Bengaluru